Neonatal opiate abstinence syndrome in term and preterm infants
- PMID: 2040931
- DOI: 10.1016/s0022-3476(05)82214-0
Neonatal opiate abstinence syndrome in term and preterm infants
Abstract
Data on 178 term and 34 preterm infants born to methadone-maintained mothers were analyzed to assess the effects of neonatal opiate abstinence in infants of varying gestational ages. More mothers in the term group (79%) than in the preterm group (53%) had abused other drugs during pregnancy (p less than 0.001). Mean (+/- SD) gestational age was 39.5 weeks +/- 1.4 for term infants and 34.3 weeks +/- 2.6 for preterm infants. On the basis of a semiobjective symptom scoring scale, term infants had more severe abstinence symptoms and more prominent central nervous system manifestations than preterm infants. The severity of abstinence symptoms correlated with maternal methadone dosage in both term and preterm infants. Maternal multiple drug abuse (e.g., heroin, cocaine) did not influence severity of abstinence symptoms in either group. More term infants (145/178) than preterm infants (20/34) required treatment for these symptoms (p less than 0.005). In 13 of 178 term infants, compared with 1 of 34 preterm infants, abstinence-related seizures developed. Peak severity occurred 1 to 2 days earlier in term than in preterm infants. A less severe abstinence syndrome in preterm infants may be due to (1) developmental immaturity of either dendritic ramifications, specific opiate receptors, or neurotransmitter function, or (2) reduced total drug exposure during the intrauterine period.
Similar articles
-
Sequela of preterm versus term infants born to mothers on a methadone maintenance program: differential course of neonatal abstinence syndrome.J Perinat Med. 2007;35(4):344-6. doi: 10.1515/JPM.2007.063. J Perinat Med. 2007. PMID: 17511598
-
Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources.BJOG. 2009 Apr;116(5):665-71. doi: 10.1111/j.1471-0528.2008.02073.x. Epub 2009 Feb 10. BJOG. 2009. PMID: 19220239
-
Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department.Neuro Endocrinol Lett. 2008 Feb;29(1):80-6. Neuro Endocrinol Lett. 2008. PMID: 18283247 Clinical Trial.
-
Treatment of neonatal abstinence syndrome.Arch Dis Child Fetal Neonatal Ed. 2003 Jan;88(1):F2-5. doi: 10.1136/fn.88.1.f2. Arch Dis Child Fetal Neonatal Ed. 2003. PMID: 12496218 Free PMC article. Review.
-
Neonatal drug addiction.Panminerva Med. 1998 Sep;40(3):239-43. Panminerva Med. 1998. PMID: 9785924 Review.
Cited by
-
Risk Factors Associated with the Occurrence of Neonatal Opioid Withdrawal Syndrome: A Review.CNS Drugs. 2019 Nov;33(11):1113-1120. doi: 10.1007/s40263-019-00681-9. CNS Drugs. 2019. PMID: 31686408 Review.
-
A survey of the management of neonatal opiate withdrawal in England and Wales.Eur J Pediatr. 1996 Apr;155(4):323-6. doi: 10.1007/BF02002721. Eur J Pediatr. 1996. PMID: 8777928
-
Opioid, methamphetamine, and polysubstance use: perinatal outcomes for the mother and infant.Front Pediatr. 2023 Dec 18;11:1305508. doi: 10.3389/fped.2023.1305508. eCollection 2023. Front Pediatr. 2023. PMID: 38250592 Free PMC article. Review.
-
Gestational Age Alters Assessment of Neonatal Abstinence Syndrome.Pediatr Rep. 2022 Jan 28;14(1):50-57. doi: 10.3390/pediatric14010009. Pediatr Rep. 2022. PMID: 35225878 Free PMC article.
-
Neurobehavioral Characterization of Perinatal Oxycodone-Exposed Offspring in Early Adolescence.J Neuroimmune Pharmacol. 2024 Jun 14;19(1):29. doi: 10.1007/s11481-024-10129-7. J Neuroimmune Pharmacol. 2024. PMID: 38874861
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical